Filter posts

Harvard Law Advocates for Patient Access to Hepatitis C Cure

There is hope for the 3.5 million people living with Hepatitis C virus (HCV) in …

Points to Consider about the Center for American Progress Prescription Drug Discussion

This afternoon, the Center for American Progress (CAP) Action Fund hosted an obviously one-sided discussion …

Facing growing pressure, N.Y. insurers agree to lift restrictions on hepatitis c therapies

Last week, we wrote about the mounting evidence of insurer discrimination and coverage denials for …

Evidence Mounts of Insurer Discrimination against HIV, HCV Patients

We’ve written before about the problem of discriminatory formulary design in health insurance plans, particularly …

New Reports: Insurance Plans Shifting More Costs to Patients

A new report out this week from the Kaiser Family Foundation showed that patient out …

San Francisco Chronicle: High Drug Co-Pays Deny Needed Treatments

Today, the San Francisco Chronicle published an op-ed that I wrote on the importance of …